From Pacer, looky as DECN stalling in patent case.
"It
From Pacer, looky as DECN stalling in patent case.
"It appears the judge wants to finish this case...
while JNJ wishes to stall... "
Knowing how to read a docket entry can be helpful. For future reference:
A "stipulation" can be filed by either party. When you see that word it means that BOTH parties have agreed to something, NOT that one of them is asking the Court for something. It's an agreement between the parties that requires the Judge's acknowledgment and approval.
The actual document (Case 2:16-cv-00564-RFB-PAL Document 60 Filed 06/13/17) says the following:
Defendants LifeScan, Inc.; LifeScan Scotland, Ltd.; and Johnson and Johnson
(collectively, “LifeScan”) and Pharma Tech Solutions, Inc. and Decision IT Corp. (collectively,
“Pharma Tech”) (together with LifeScan, the “Parties”) file this Stipulation and [Proposed] Order
to Modify Discovery Deadline and Briefing Schedule for Expedited Motion for Summary
Judgment. The Parties seek the following adjustments to the Court’s March 13, 2017 Order (D.I.
48) in order to provide additional time for expert depositions and to adjust the briefing schedule
for the expedited partial motion for summary judgment in this case:
• an extension of the discovery period until July 24, 2017;
• a two-week extension to submit LifeScan’s expedited motion for summary
judgment until July 24, 2017;
• a three-week extension to submit Pharma Tech’s response until August 28, 2017;
• a three-week extension to submit LifeScan’s reply until September 18, 2017.
With a REAL Pacer account the reading of the actual documents will tend to reduce the likelihood of the regular misinterpretation of the docket summary line and I wouldn't be out 40 cents.
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Mobix Labs Secures AI Drone Contract Mobix Labs, Inc. (NASDAQ: MOBX), a leading provider in advanced connectivity and sensing solutions, has embarked on an exciting journey with a new contract for its Mobix Labs Wireless division, RaGE Systems. They are set to develop cutting-edge drone-based, AI-powered inspection technology specifically for the U.S. rail industry. This...
Continue Reading
Groundbreaking NIH Grant for Lactiga's Antibody Research Lactiga US, Inc., a pioneering biotechnology firm, has secured an important award from the National Institutes of Health (NIH) to enhance the development of its first-in-class secretory IgA (sIgA) antibody targeting inflammatory bowel disease (IBD). Understanding the Power of Breastmilk-Derived Antibodies This...
Continue Reading
Market Growth Overview of Intelligent Electronic Devices The Intelligent Electronic Devices (IED) market is on an impressive trajectory, expected to reach USD 33.49 Billion, increasing significantly from its valuation of USD 14.35 Billion in the near future. This growth reflects a compound annual growth rate (CAGR) of 11.18% between now and 2032. The exciting advancements...
Continue Reading
Exploring Undervalued Energy Stocks for Portfolio Growth As market conditions fluctuate, the energy sector presents intriguing opportunities for investors seeking to enhance their portfolios. With numerous stocks labeled as oversold, there is potential for significant gains. Seeking out undervalued stocks could be a wise strategy, especially those showing a relative...
Continue Reading
Pixi Beauty Introduces Three New Blush Shades Pixi Beauty has recently expanded its popular On-the-Glow Blush collection by adding three exciting new shades: Mauve, Cassis, and Chantilly. These versatile colors are designed to streamline beauty routines with a multi-use balm that enhances your natural beauty effortlessly. The Shift Toward Natural Beauty As the beauty...
Continue Reading